Can Pharmacovigilance meet the COVID-19 Challenge?
A checklist approach to PV Business Continuity
In this new world, driven by COVID-19, there is pressure on pharma companies to accelerate their drug development while, at the same time, maintaining integrity of their PV operations. The level of vigilance for patient safety must not be compromised.
Please complete the form to download our paper – Can Pharmacovigilance meet the COVID-19 challenge?
© 2020 Navitas Life Sciences | Privacy Policy